A citation-based method for searching scientific literature

Michelle W Wong-Brown, Kelly A Avery-Kiejda, Nikola A Bowden, Rodney J Scott. Int J Cancer 2014
Times Cited: 12







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Tuomas Heikkinen, Hanni Kärkkäinen, Kirsimari Aaltonen, Roger L Milne, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna. Clin Cancer Res 2009
98
66

A recurrent mutation in PALB2 in Finnish cancer families.
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko,[...]. Nature 2007
322
66

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.
Agnieszka Dansonka-Mieszkowska, Anna Kluska, Joanna Moes, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Pawel Derlatka, Krzysztof Cendrowski, Jolanta Kupryjanczyk. BMC Med Genet 2010
86
66

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
670
58

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
513
58

Novel germline PALB2 truncating mutations in African American breast cancer patients.
Yonglan Zheng, Jing Zhang, Qun Niu, Dezheng Huo, Olufunmilayo I Olopade. Cancer 2012
30
50

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
172
50

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.
Zhi L Teo, Daniel J Park, Elena Provenzano, Catherine A Chatfield, Fabrice A Odefrey, Tu Nguyen-Dumont, James G Dowty, John L Hopper, Ingrid Winship, David E Goldgar,[...]. Breast Cancer Res 2013
33
50

Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore.
Sze Yee Phuah, Sheau Yee Lee, Peter Kang, In Nee Kang, Sook-Yee Yoon, Meow Keong Thong, Mikael Hartman, Jen-Hwei Sng, Cheng Har Yip, Nur Aishah Mohd Taib,[...]. PLoS One 2013
23
50

Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
María J García, Victoria Fernández, Ana Osorio, Alicia Barroso, Gemma Llort, Conxi Lázaro, Ignacio Blanco, Trinidad Caldés, Miguel de la Hoya, Teresa Ramón Y Cajal,[...]. Breast Cancer Res Treat 2009
73
50

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
398
50

PALB2/FANCN: recombining cancer and Fanconi anemia.
Marc Tischkowitz, Bing Xia. Cancer Res 2010
126
41

PALB2: a novel inactivating mutation in a Italian breast cancer family.
Cristina Balia, Elisa Sensi, Grazia Lombardi, Manuela Roncella, Generoso Bevilacqua, Maria Adelaide Caligo. Fam Cancer 2010
27
41

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
569
41

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.
Irene Catucci, Paolo Peterlongo, Sara Ciceri, Mara Colombo, Graziella Pasquini, Monica Barile, Bernardo Bonanni, Paolo Verderio, Sara Pizzamiglio, Claudia Foglia,[...]. Genet Med 2014
21
41

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.
Ana Blanco, Miguel de la Hoya, Judith Balmaña, Teresa Ramón y Cajal, Alex Teulé, María-Dolores Miramar, Eva Esteban, Mar Infante, Javier Benítez, Asunción Torres,[...]. Breast Cancer Res Treat 2012
39
41

PALB2 mutations in German and Russian patients with bilateral breast cancer.
Natalia Bogdanova, Anna P Sokolenko, Aglaya G Iyevleva, Svetlana N Abysheva, Magda Blaut, Michael Bremer, Hans Christiansen, Margret Rave-Fränk, Thilo Dörk, Evgeny N Imyanitov. Breast Cancer Res Treat 2011
41
41

PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu. Curr Biol 2009
347
41

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
William D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, Nancy Hamel, Sylvie Giroux, Nelly Sabbaghian, Andrew Darnel, Robert Royer, Aletta Poll, Eve Fafard,[...]. Breast Cancer Res 2007
107
41

Analysis of PALB2/FANCN-associated breast cancer families.
Marc Tischkowitz, Bing Xia, Nelly Sabbaghian, Jorge S Reis-Filho, Nancy Hamel, Guilan Li, Erik H van Beers, Lili Li, Tayma Khalil, Louise A Quenneville,[...]. Proc Natl Acad Sci U S A 2007
166
41

Germline mutations in PALB2 in African-American breast cancer cases.
Yuan Chun Ding, Linda Steele, Li-Hao Chu, Karen Kelley, Helen Davis, Esther M John, Gail E Tomlinson, Susan L Neuhausen. Breast Cancer Res Treat 2011
26
41

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Gross, Barbara Wappenschmidt, Christian Schem, Helmut Deissler, Nina Ditsch, Verena Gress, Marion Kiechle,[...]. Hum Mutat 2011
41
33

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
A-Yong Cao, Juan Huang, Zhen Hu, Wen-Feng Li, Zhong-Liang Ma, Li-Li Tang, Bin Zhang, Feng-Xi Su, Jie Zhou, Gen-Hong Di,[...]. Breast Cancer Res Treat 2009
66
33

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.
Marc Tischkowitz, Marinela Capanu, Nelly Sabbaghian, Lili Li, Xiaolin Liang, Maxime P Vallée, Sean V Tavtigian, Patrick Concannon, William D Foulkes, Leslie Bernstein,[...]. Hum Mutat 2012
60
33

A PALB2 mutation associated with high risk of breast cancer.
Melissa C Southey, Zhi L Teo, James G Dowty, Fabrice A Odefrey, Daniel J Park, Marc Tischkowitz, Nelly Sabbaghian, Carmel Apicella, Graham B Byrnes, Ingrid Winship,[...]. Breast Cancer Res 2010
89
33

PALB2 mutations in familial breast and pancreatic cancer.
Erin W Hofstatter, Susan M Domchek, Alexander Miron, Judy Garber, Molin Wang, Kathryn Componeschi, Leigh Boghossian, Penelope L Miron, Katherine L Nathanson, Nadine Tung. Fam Cancer 2011
78
33

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
Ana Blanco, Miguel de la Hoya, Ana Osorio, Orland Diez, María Dolores Miramar, Mar Infante, Cristina Martinez-Bouzas, Asunción Torres, Adriana Lasa, Gemma Llort,[...]. PLoS One 2013
35
33

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.
Cezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, Dominika Wokołorczyk, Aniruddh Kashyap, Anna Jakubowska, Marek Szwiec, Tomasz Byrski, Tadeusz Dębniak, Bohdan Górski,[...]. Lancet Oncol 2015
100
33

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
173
25

Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
J-Y Park, T R Singh, N Nassar, F Zhang, M Freund, H Hanenberg, A R Meetei, P R Andreassen. Oncogene 2014
86
25

MRG15 is a novel PALB2-interacting factor involved in homologous recombination.
Shirley M-H Sy, Michael S Y Huen, Junjie Chen. J Biol Chem 2009
52
25

Penetrance analysis of the PALB2 c.1592delT founder mutation.
Hannele Erkko, James G Dowty, Jenni Nikkilä, Kirsi Syrjäkoski, Arto Mannermaa, Katri Pylkäs, Melissa C Southey, Kaija Holli, Anne Kallioniemi, Arja Jukkola-Vuorinen,[...]. Clin Cancer Res 2008
77
25

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.
Franziska Pern, Natalia Bogdanova, Peter Schürmann, Min Lin, Aysun Ay, Florian Länger, Peter Hillemanns, Hans Christiansen, Tjoung-Won Park-Simon, Thilo Dörk. PLoS One 2012
39
25

Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
Priscilla H Fernandes, Jennifer Saam, Jenny Peterson, Elisha Hughes, Rajesh Kaldate, Shelly Cummings, Aaron Theisen, Sonia Chen, Jeffrey Trost, Benjamin B Roa. Cancer 2014
20
25

PALB2 and breast cancer: ready for clinical translation!
Melissa C Southey, Zhi L Teo, Ingrid Winship. Appl Clin Genet 2013
32
25

A PALB2 germline mutation associated with hereditary breast cancer in Italy.
Laura Papi, Anna Laura Putignano, Caterina Congregati, Irene Piaceri, Ines Zanna, Francesco Sera, Doralba Morrone, Maurizio Genuardi, Domenico Palli. Fam Cancer 2010
37
25

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.
Michelle W Wong, Cecilia Nordfors, David Mossman, Gordana Pecenpetelovska, Kelly A Avery-Kiejda, Bente Talseth-Palmer, Nikola A Bowden, Rodney J Scott. Breast Cancer Res Treat 2011
71
25

PALB2 analysis in BRCA2-like families.
M A Adank, S E van Mil, J J P Gille, Q Waisfisz, H Meijers-Heijboer. Breast Cancer Res Treat 2011
34
25

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Sarah Reid, Detlev Schindler, Helmut Hanenberg, Karen Barker, Sandra Hanks, Reinhard Kalb, Kornelia Neveling, Patrick Kelly, Sheila Seal, Marcel Freund,[...]. Nat Genet 2007
442
25

PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
Paolo Peterlongo, Irene Catucci, Graziella Pasquini, Paolo Verderio, Bernard Peissel, Monica Barile, Liliana Varesco, Mirko Riboni, Stefano Fortuzzi, Siranoush Manoukian,[...]. Breast Cancer Res Treat 2011
29
25

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Bing Xia, Josephine C Dorsman, Najim Ameziane, Yne de Vries, Martin A Rooimans, Qing Sheng, Gerard Pals, Abdellatif Errami, Eliane Gluckman, Julian Llera,[...]. Nat Genet 2007
342
25

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
549
25

Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.
Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, Helen Tsimiklis, Zhi L Teo, Roger Li, Bernard J Pope, Mary Beth Terry, Saundra S Buys, Mary Daly,[...]. Breast Cancer Res Treat 2015
20
25


Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
Yessica Leyton, Patricio Gonzalez-Hormazabal, Rafael Blanco, Teresa Bravo, Ricardo Fernandez-Ramires, Sebastian Morales, Natalia Landeros, Jose M Reyes, Octavio Peralta, Julio C Tapia,[...]. BMC Cancer 2015
15
25

A method and server for predicting damaging missense mutations.
Ivan A Adzhubei, Steffen Schmidt, Leonid Peshkin, Vasily E Ramensky, Anna Gerasimova, Peer Bork, Alexey S Kondrashov, Shamil R Sunyaev. Nat Methods 2010
25

Human Splicing Finder: an online bioinformatics tool to predict splicing signals.
François-Olivier Desmet, Dalil Hamroun, Marine Lalande, Gwenaëlle Collod-Béroud, Mireille Claustres, Christophe Béroud. Nucleic Acids Res 2009
25

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
25

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
366
25

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, Yolanda Jerez, María Del Monte-Millán, Tatiana Massarrah, Rocío Ramos-Medina, Inmaculada Ocaña, Antoni Picornell, Sonia Santillán Garzón,[...]. Breast Cancer Res Treat 2016
22
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.